Insider Transactions in Q4 2020 at Kezar Life Sciences, Inc. (KZR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
John Franklin Fowler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+4.26%
|
$0
$0.9 P/Share
|